| Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening. | |
| | |
MedLine Citation:
|
PMID: 20451698 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The coronary vasodilatory effect of dipyridamole is competitively blocked by caffeine. The purposes of this study were to (1) assess the incidence of having detectable serum caffeine and (2) evaluate whether an intensive caffeine history screening strategy was superior to routine history screening before dipyridamole myocardial perfusion imaging. One hundred ninety-four patients who were randomized to an intensive or a routine screening history strategy were prospectively evaluated. Serum caffeine levels were determined in all patients. Outcomes data, including death, nonfatal myocardial infarction, and history of revascularization, were obtained at 24 months. Nearly 1 in 5 patients (19%) who screened negative by history had detectable serum caffeine. In patients who screened negative by history, there was no statistically significant difference in the percentage of caffeine seropositivity between the intensive and routine arms (16% vs 22%, respectively, p = 0.31). The incidence of combined end points of death, myocardial infarction, or revascularization was 22.9% and 7.3% in patients with and without detectable serum caffeine, respectively (p = 0.01). In conclusion, despite initial negative results on screening by history, a considerably high percentage of patients had positive serum caffeine levels. These results do not support the use of an intensive screening strategy. Detectable serum caffeine was associated with a higher incidence of adverse outcomes. |
| | |
Authors:
|
Lesan T Banko; Salman A Haq; Debroah A Rainaldi; Igor Klem; Jason Siegler; Joshua Fogel; Terrence J Sacchi; John F Heitner |
Related Documents
:
|
836348 - Serum 25-hydroxycalciferol in myocardial infarction. 1563878 - Reliability in the interpretation of the course of serum enzyme concentration changes i... 6745288 - Cardiac arrhythmias following acute myocardial infarction: associations with the serum ... 23639508 - Echogenic focus in the fetal left ventricular cavity: is it a false tendon? 2013158 - Estimation of myocardial infarct size with ultrasonic tissue characterization. 17826648 - Systolic and diastolic heart failure: differences and similarities. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial Date: 2010-04-08 |
Journal Detail:
|
Title: The American journal of cardiology Volume: 105 ISSN: 1879-1913 ISO Abbreviation: Am. J. Cardiol. Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-10 Completed Date: 2010-06-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 1474-9 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright 2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
New York Methodist Hospital, Brooklyn, New York, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Caffeine / adverse effects, blood*, pharmacology Coronary Disease / blood, radionuclide imaging* Dipyridamole / diagnostic use*, pharmacology Drug Interactions Exercise Test / methods* Female Hemodynamics / drug effects Humans Incidence Male Mass Screening / methods Medical History Taking / methods Middle Aged Multivariate Analysis Myocardial Infarction / epidemiology, etiology Myocardial Perfusion Imaging / methods* Prospective Studies Reference Values Regression Analysis Risk Factors Sensitivity and Specificity Vasodilator Agents / diagnostic use, pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Vasodilator Agents; 58-08-2/Caffeine; 58-32-2/Dipyridamole |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Heart rate recovery after exercise in adults with the Down syndrome.
Next Document: Association between serum lipoproteins and abdominal aortic aneurysm.